Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Modeling neurodegenerative Spinocerebellar Ataxia type 13 in zebrafish using a Purkinje neuron specific tunable co-expression system.

Namikawa K, Dorigo A, Zagrebelsky M, Russo G, Kirmann T, Fahr W, Dübel S, Korte M, Köster RW.

J Neurosci. 2019 Mar 12. pii: 1862-18. doi: 10.1523/JNEUROSCI.1862-18.2019. [Epub ahead of print]

PMID:
30862666
2.

Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions.

Yasue C, Chino A, Takamatsu M, Namikawa K, Ide D, Saito S, Igarashi M, Fujisaki J.

J Gastroenterol. 2019 Feb 27. doi: 10.1007/s00535-019-01564-y. [Epub ahead of print]

PMID:
30810812
3.

Intimal regeneration after coronary endarterectomy and onlay grafting in coronary artery bypass grafting.

Okada T, Minato N, Kanemoto SY, Zempo N, Saiga K, Namikawa K, Kanno S, Ueno H.

Gen Thorac Cardiovasc Surg. 2019 Feb 21. doi: 10.1007/s11748-019-01083-w. [Epub ahead of print]

PMID:
30790237
4.

Age- and α-Synuclein-Dependent Degeneration of Dopamine and Noradrenaline Neurons in the Annual Killifish Nothobranchius furzeri.

Matsui H, Kenmochi N, Namikawa K.

Cell Rep. 2019 Feb 12;26(7):1727-1733.e6. doi: 10.1016/j.celrep.2019.01.015.

5.

Targeted Therapy and Immunotherapy for Melanoma in Japan.

Namikawa K, Yamazaki N.

Curr Treat Options Oncol. 2019 Jan 24;20(1):7. doi: 10.1007/s11864-019-0607-8. Review.

6.

Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.

Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y.

Gastric Cancer. 2018 Nov 22. doi: 10.1007/s10120-018-0900-4. [Epub ahead of print]

PMID:
30467737
7.

Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study.

Namikawa K, Kiyohara Y, Takenouchi T, Uhara H, Uchi H, Yoshikawa S, Takatsuka S, Koga H, Wada N, Minami H, Hatsumichi M, Asada S, Namba Y, Yamazaki N.

Eur J Cancer. 2018 Dec;105:114-126. doi: 10.1016/j.ejca.2018.09.025. Epub 2018 Nov 15.

8.

Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.

Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y.

Gastric Cancer. 2018 Oct 17. doi: 10.1007/s10120-018-0887-x. [Epub ahead of print] Erratum in: Gastric Cancer. 2018 Nov 22;:.

PMID:
30328533
9.

Surgery with curative intent is associated with prolonged survival in patients with cutaneous angiosarcoma of the scalp and face -a retrospective study of 38 untreated cases in the Japanese population.

Oashi K, Namikawa K, Tsutsumida A, Takahashi A, Itami J, Igaki H, Inaba K, Yamazaki N.

Eur J Surg Oncol. 2018 Jun;44(6):823-829. doi: 10.1016/j.ejso.2018.02.246. Epub 2018 Mar 6.

PMID:
29555155
10.

Fulminant type 1 diabetes associated with nivolumab in a patient with metastatic melanoma.

Takahashi A, Tsutsumida A, Namikawa K, Yamazaki N.

Melanoma Res. 2018 Apr;28(2):159-160. doi: 10.1097/CMR.0000000000000418. No abstract available.

PMID:
29485550
12.

Phase 1/2 study assessing the safety and efficacy of dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced cutaneous melanoma.

Yamazaki N, Tsutsumida A, Takahashi A, Namikawa K, Yoshikawa S, Fujiwara Y, Kondo S, Mukaiyama A, Zhang F, Kiyohara Y.

J Dermatol. 2018 Apr;45(4):397-407. doi: 10.1111/1346-8138.14210. Epub 2018 Feb 5.

13.

Success of rechallenging dabrafenib and trametinib combination therapy after trametinib-induced rhabdomyolysis: a case report.

Muto Y, Ng W, Namikawa K, Takahashi A, Tsutsumida A, Nishida M, Yamazaki N.

Melanoma Res. 2018 Apr;28(2):151-154. doi: 10.1097/CMR.0000000000000424.

PMID:
29356791
14.

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON).

Namikawa K, Tsutsumida A, Mizutani T, Shibata T, Takenouchi T, Yoshikawa S, Kiyohara Y, Uchi H, Furue M, Ogata D, Tsuchida T, Yamazaki N.

Jpn J Clin Oncol. 2017 Jul 1;47(7):664-667. doi: 10.1093/jjco/hyx063.

15.

Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF V600 mutation-positive solid tumors: a phase 1 study.

Fujiwara Y, Yamazaki N, Kiyohara Y, Yoshikawa S, Yamamoto N, Tsutsumida A, Nokihara H, Namikawa K, Mukaiyama A, Zhang F, Tamura T.

Invest New Drugs. 2018 Apr;36(2):259-268. doi: 10.1007/s10637-017-0502-8. Epub 2017 Sep 7.

PMID:
28879519
16.

Rapidly developed BRAF inhibitor-induced verrucous keratosis.

Nakamura Y, Mori T, Takae Y, Tsutsumida A, Takahashi A, Namikawa K, Hirai I, Yamazaki N.

J Dermatol. 2017 Nov;44(11):e274-e275. doi: 10.1111/1346-8138.13962. Epub 2017 Jul 22. No abstract available.

PMID:
28734005
17.

Characteristics of melanoma in Japan: a nationwide registry analysis 2011-2013.

Tomizuka T, Namikawa K, Higashi T.

Melanoma Res. 2017 Oct;27(5):492-497. doi: 10.1097/CMR.0000000000000375.

PMID:
28609317
18.

Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population.

Shibayama Y, Namikawa K, Sone M, Takahashi A, Tsutsumida A, Sugawara S, Arai Y, Aihara Y, Suzuki S, Nakayama J, Imafuku S, Yamazaki N.

Int J Clin Oncol. 2017 Jun;22(3):577-584. doi: 10.1007/s10147-017-1095-0. Epub 2017 Jan 31.

PMID:
28144882
19.

Sequential Combination Chemotherapy of Dacarbazine (DTIC) with Carboplatin and Paclitaxel for Patients with Metastatic Mucosal Melanoma of Nasal Cavity and Paranasal Sinuses.

Omata W, Tsutsumida A, Namikawa K, Takahashi A, Oashi K, Yamazaki N.

Clin Med Insights Case Rep. 2017 Jan 9;10:1-5. doi: 10.4137/CCRep.S39851. eCollection 2017.

20.

Design of a prototype split-and-delay unit for XFEL pulses, and their evaluation by synchrotron radiation X-rays.

Sakamoto J, Ohwada K, Ishino M, Mizuki J, Ando M, Namikawa K.

J Synchrotron Radiat. 2017 Jan 1;24(Pt 1):95-102. doi: 10.1107/S1600577516017744. Epub 2017 Jan 1.

PMID:
28009550
21.

Caspase-mediated apoptosis induction in zebrafish cerebellar Purkinje neurons.

Weber T, Namikawa K, Winter B, Müller-Brown K, Kühn R, Wurst W, Köster RW.

Development. 2016 Nov 15;143(22):4279-4287. Epub 2016 Oct 11.

22.

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy.

Nakamura Y, Kitano S, Takahashi A, Tsutsumida A, Namikawa K, Tanese K, Abe T, Funakoshi T, Yamamoto N, Amagai M, Yamazaki N.

Oncotarget. 2016 Nov 22;7(47):77404-77415. doi: 10.18632/oncotarget.12677.

23.

Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease.

Tanaka R, Sasajima Y, Tsuda H, Namikawa K, Takahashi A, Tsutsumida A, Fujisawa Y, Fujimoto M, Yamazaki N.

Clin Exp Metastasis. 2016 Oct;33(7):687-97. doi: 10.1007/s10585-016-9804-z. Epub 2016 Jun 11.

PMID:
27289366
24.

[Update on Evidence-Based Review for the Management of Cutaneous Melanoma].

Namikawa K.

Gan To Kagaku Ryoho. 2016 Apr;43(4):420-4. Japanese. No abstract available.

PMID:
27254880
25.

Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in Japan.

Tsutsumida A, Takahashi A, Namikawa K, Yamazaki N, Uhara H, Teramoto Y, Takenouchi T, Fukushima S, Yokota K, Uehara J, Matsushita S, Shibayama Y, Hatta N, Masui Y, Uchi H, Fujisawa Y, Ogata D.

Int J Clin Oncol. 2016 Aug;21(4):796-800. doi: 10.1007/s10147-015-0944-y. Epub 2016 Jan 13.

PMID:
26759315
26.

Identification of the zebrafish red nucleus using Wheat Germ Agglutinin transneuronal tracing.

Matsui H, Namikawa K, Köster RW.

Commun Integr Biol. 2014 Dec 31;7(6):e994383. doi: 10.4161/19420889.2014.994383. eCollection 2014 Dec.

27.

Demonstration of the high collection efficiency of a broadband Mo/Si multilayer mirror with a graded multilayer coating on an ellipsoidal substrate.

Ichimaru S, Takenaka H, Namikawa K, Gullikson EM, Maruyama M, Oku S.

Rev Sci Instrum. 2015 Sep;86(9):093106. doi: 10.1063/1.4929708.

PMID:
26429428
28.

Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanoma.

Yamazaki N, Uhara H, Fukushima S, Uchi H, Shibagaki N, Kiyohara Y, Tsutsumida A, Namikawa K, Okuyama R, Otsuka Y, Tokudome T.

Cancer Chemother Pharmacol. 2015 Nov;76(5):969-75. doi: 10.1007/s00280-015-2870-0. Epub 2015 Sep 25.

29.

BRAF V600 mutations and pathological features in Japanese melanoma patients.

Yamazaki N, Tanaka R, Tsutsumida A, Namikawa K, Eguchi H, Omata W, Oashi K, Ogawa T, Hayashi A, Nakamura N, Tsuta K.

Melanoma Res. 2015 Feb;25(1):9-14. doi: 10.1097/CMR.0000000000000091.

30.

Functional regionalization of the teleost cerebellum analyzed in vivo.

Matsui H, Namikawa K, Babaryka A, Köster RW.

Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11846-51. doi: 10.1073/pnas.1403105111. Epub 2014 Jul 7.

31.

Canine Orientia tsutsugamushi infection: report of a case and its epidemicity.

Namikawa K, Tanabe A, Satake S, Enishi H, Kusaka H, Ide N, Neo S, Lynch J, Orito K, Morita T, Sahara H.

Southeast Asian J Trop Med Public Health. 2014 Mar;45(2):395-401.

PMID:
24968681
32.

Case of advanced melanoma who died from meningitis carcinomatosa after carboplatin and paclitaxel with good response.

Kato J, Tsutsumida A, Namikawa K, Tanaka R, Yamazaki N.

J Dermatol. 2014 Jul;41(7):654-5. doi: 10.1111/1346-8138.12535. Epub 2014 Jun 18. No abstract available.

PMID:
24942695
33.

Combination chemotherapy for metastatic extramammary Paget disease.

Oashi K, Tsutsumida A, Namikawa K, Tanaka R, Omata W, Yamamoto Y, Yamazaki N.

Br J Dermatol. 2014 Jun;170(6):1354-7. doi: 10.1111/bjd.12788.

PMID:
24329551
34.
35.

N-terminal cleaved pancreatitis-associated protein-III (PAP-III) serves as a scaffold for neurites and promotes neurite outgrowth.

Konishi H, Matsumoto S, Namikawa K, Kiyama H.

J Biol Chem. 2013 Apr 12;288(15):10205-13. doi: 10.1074/jbc.M112.395301. Epub 2013 Feb 20.

36.

Limitation of indocyanine green fluorescence in identifying sentinel lymph node prior to skin incision in cutaneous melanoma.

Namikawa K, Tsutsumida A, Tanaka R, Kato J, Yamazaki N.

Int J Clin Oncol. 2014 Feb;19(1):198-203. doi: 10.1007/s10147-013-0524-y. Epub 2013 Feb 1.

PMID:
23371310
37.

Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease.

Tanaka R, Sasajima Y, Tsuda H, Namikawa K, Tsutsumida A, Otsuka F, Yamazaki N.

Br J Dermatol. 2013 Jun;168(6):1259-66. doi: 10.1111/bjd.12249.

PMID:
23360223
38.

A case of scalp angiosarcoma with lung metastases presenting as multiple thin-walled cysts.

Namikawa K, Yamazaki N.

Jpn J Clin Oncol. 2013 Jan;43(1):101. doi: 10.1093/jjco/hys224. No abstract available.

PMID:
23271634
39.

Evaluation of arene ruthenium(II) N-heterocyclic carbene complexes as organometallics interacting with thiol and selenol containing biomolecules.

Oehninger L, Stefanopoulou M, Alborzinia H, Schur J, Ludewig S, Namikawa K, Muñoz-Castro A, Köster RW, Baumann K, Wölfl S, Sheldrick WS, Ott I.

Dalton Trans. 2013 Feb 7;42(5):1657-66. doi: 10.1039/c2dt32319b. Epub 2012 Nov 14.

PMID:
23149817
40.

A double-blind, placebo-controlled study of the safety and efficacy of vitamin K1 ointment for the treatment of patients with cetuximab-induced acneiform eruption.

Hashimoto H, Iwasa S, Yanai T, Honma Y, Kato K, Hamaguchi T, Yamada Y, Shimada Y, Namikawa K, Tsutsumida A, Yamazaki N, Yamamoto H.

Jpn J Clin Oncol. 2013 Jan;43(1):92-4. doi: 10.1093/jjco/hys183. Epub 2012 Nov 6.

PMID:
23136238
41.

Gingival overgrowth in a dog that received long-term cyclosporine for immune-mediated hemolytic anemia.

Namikawa K, Maruo T, Honda M, Hirata H, Lynch J, Madarame H.

Can Vet J. 2012 Jan;53(1):67-70.

42.

Booster effect of canine distemper, canine parvovirus infection and infectious canine hepatitis combination vaccine in domesticated adult dogs.

Taguchi M, Namikawa K, Maruo T, Orito K, Lynch J, Tsuchiya R, Sahara H.

Microbiol Immunol. 2012 Aug;56(8):579-82. doi: 10.1111/j.1348-0421.2012.00475.x.

43.

[Guideline for the management of melanoma: outline and point of revision-novel chemotherapy-].

Namikawa K.

Gan To Kagaku Ryoho. 2012 Apr;39(4):533-7. Japanese. No abstract available.

PMID:
22662360
44.

Catalytic azide reduction in biological environments.

Sasmal PK, Carregal-Romero S, Han AA, Streu CN, Lin Z, Namikawa K, Elliott SL, Köster RW, Parak WJ, Meggers E.

Chembiochem. 2012 May 29;13(8):1116-20. doi: 10.1002/cbic.201100719. Epub 2012 Apr 19.

PMID:
22514188
45.

Antibody titers for canine parvovirus type-2, canine distemper virus, and canine adenovirus type-1 in adult household dogs.

Taguchi M, Namikawa K, Maruo T, Orito K, Lynch J, Sahara H.

Can Vet J. 2011 Sep;52(9):983-6.

46.

Four promising antigens, BgP32, BgP45, BgP47, and BgP50, for serodiagnosis of Babesia gibsoni infection were classified as B. gibsoni merozoite surface protein family.

Goo YK, Aboge GO, Terkawi MA, Jia H, Yamagishi J, Sunaga F, Namikawa K, Cha SY, Jang HK, Kim S, Nishikawa Y, Xuan X.

Parasitol Int. 2012 Jun;61(2):364-8. doi: 10.1016/j.parint.2011.11.007. Epub 2011 Dec 8.

PMID:
22172478
47.

IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation.

Oberoi TK, Dogan T, Hocking JC, Scholz RP, Mooz J, Anderson CL, Karreman C, Meyer zu Heringdorf D, Schmidt G, Ruonala M, Namikawa K, Harms GS, Carpy A, Macek B, Köster RW, Rajalingam K.

EMBO J. 2012 Jan 4;31(1):14-28. doi: 10.1038/emboj.2011.423. Epub 2011 Nov 25.

48.

Prediction of additional lymph node positivity and clinical outcome of micrometastases in sentinel lymph nodes in cutaneous melanoma: a multi-institutional study of 450 patients in Japan.

Namikawa K, Yamazaki N, Nakai Y, Ihn H, Tomita Y, Uhara H, Takenouchi T, Kiyohara Y, Moroi Y, Yamamoto Y, Otsuka F, Kamiya H, Iizuka H, Hatta N, Kadono T.

J Dermatol. 2012 Feb;39(2):130-7. doi: 10.1111/j.1346-8138.2011.01318.x. Epub 2011 Sep 28.

PMID:
21950448
49.

Efficacy of taxane regimens in patients with metastatic angiosarcoma.

Hirata T, Yonemori K, Ando M, Hirakawa A, Tsuda H, Hasegawa T, Chuman H, Namikawa K, Yamazaki N, Fujiwara Y.

Eur J Dermatol. 2011 Jul-Aug;21(4):539-45. doi: 10.1684/ejd.2011.1403.

PMID:
21697045
50.

An outbreak of Trixacarus caviae infestation in guinea pigs at an animal petting facility and an evaluation of the safety and suitable dose of selamectin treatment.

Honda M, Namikawa K, Hirata H, Neo S, Maruo T, Lynch J, Chida A, Morita T.

J Parasitol. 2011 Aug;97(4):731-4. doi: 10.1645/GE-2725.1. Epub 2011 Feb 16.

PMID:
21506831

Supplemental Content

Loading ...
Support Center